Results
|
1.
|
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. MedStar authors:
Year: 2017
Citation: - Cancer. 123(23):4640-4647, 2017 Dec 01
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Chawla SP, Kaiser PE, Milhem MM, Portnoy DC, Priebat DA, Samuels BL, Skubitz KM, Somaiah N, Staddon AP, Stepanski EJ, Walker MS
|
|
2.
|
|
|
3.
|
Effect of Bleeding Risk on Type of Stent Used in Patients Presenting With Acute Coronary Syndrome. MedStar authors:
- Alraies, M Chadi
- Ben-Dor, Itsik
- Buchanan, Kyle
- Gai, Jiaxiang
- Koifman, Edward
- Lee, Sang Yeub
- Lipinski, Michael J
- Pichard, Augusto D
- Rogers, Toby
- Satler, Lowell F
- Steinvil, Arie
- Torguson, Rebecca
- Waksman, Ron
Year: 2017
Citation: - American Journal of Cardiology. 120(8):1272-1278, 2017 Oct 15
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alraies MC, Ben-Dor I, Buchanan K, Gai J, Koifman E, Lee SY, Lipinski MJ, Pichard AD, Rogers T, Satler LF, Steinvil A, Torguson R, Waksman R
|
|
4.
|
The CLOSER trial: a multi-center study on the clinical safety and effectiveness of closer<sup>TM</sup> VSS, a novel resorbable transfemoral vascular access sealing system. MedStar authors:
Year: 2017
Citation: - Catheterization & Cardiovascular Interventions. 90(5):798-805, 2017 Nov 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bachinsky W, Bergman G, Bernardo N, Cavros N, Gammon R, Jaff MR, Leimbach W, Liu PY, O'Shaughnessy C, Wong SC
|
|
5.
|
Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). MedStar authors:
Year: 2017
Citation: - Diabetic Medicine. 34(12):1747-1755, 2017 Dec.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Knowler WC, Mather KJ, Pan Q, Perreault L, The Diabetes Prevention Program Research Group
|